| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 512.45 | 29.9% | 31.4% |
| Total Income | 514.55 | 30.4% | 33.1% |
| Expenditure | 454.60 | 31.5% | 39.0% |
| PBT | 59.95 | 20.6% | 0.8% |
| Net Profit | 60.59 | 6.0% | 11.8% |
| OPM | 24.88% | 6.31pp | 24.42pp |
| NPM | 11.78% | 4.05pp | 2.24pp |
| EPS | 4.31 | 9.7% | 67.7% |
Anupam Rasayan India Ltd Reports Q3FY26 Results: 33% YoY Growth in Total Revenue, 7% YoY Growth in EBITDA, and 12% YoY Growth in PAT
14 Feb 2026 · 14 Feb, 12:22 pm
Summary
Anupam Rasayan India Ltd, a leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended December 31, 2025. The company reported a 33% YoY growth in total revenue, a 7% YoY growth in EBITDA, and a 12% YoY growth in PAT.
Key Highlights
- 1
Q3FY26 Total Revenue: %5,145 Mn; YOY Growth at 33%
- 2
Q3FY26 EBITDA: 1,296 Mn; YOY Growth at 7%
- 3
Q3FY26 PAT: %606 Mn; YOY Growth at 12%
- 4
Signed a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States
- 5
Consolidated revenue of 317,297 million with EBITDA of 24,024 million for the nine months of FY26
Management Comments
Mr Anand Desai
Managing Director
I am pleased to share that for the nine months of FY26, we delivered consolidated revenue of 317,297 million with EBITDA of 24,024 million, reflecting strong year-on-year growth. For Q3 FY26, revenue stood at %5,124 million with EBITDA of 1,296 million, demonstrating continued growth momentum. A significant strategic development during the period has been the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States.
Informational and educational content only. Not investment advice.